Allergan Aesthetics, an AbbVie company, has partnered with New York entrepreneur and television personality Erin Lichy, who is speaking publicly about her recent breast augmentation using Natrelle breast implants to promote transparency and normalize conversations around aesthetic procedures.

 

A mother of four, Lichy says her decision follows years of physical change after pregnancy and breastfeeding, and reflects a personal journey toward renewed body confidence. Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms.

 

"Motherhood and breastfeeding changed my body in ways I didn't fully expect, and I found myself wanting to feel more like me again," said Erin Lichy. 

 

"I didn't originally consider breast implants because I was looking for an understated result, but after sharing my aesthetic goals with board-certified plastic surgeon Dr. Ira Savetsky, we chose Natrelle implants. It was a very educational conversation. We talked about projection, profile, the safety of the implant and how they would look on my body. I'm thrilled with my results, and I'm sharing my experience to help other women feel more confident to explore their own options."

 

Allergan says the collaboration is intended to encourage more open dialogue around breast augmentation and help women feel informed before seeking consultations.

 

"Every woman's aesthetic journey is unique. Erin's transparency and willingness to share her story fosters connection for other women," said Nicole Mowad-Nassar, President, Global Allergan Aesthetics and Senior Vice President, AbbVie. "Honest conversations are the first step in helping women who may be interested in breast augmentation feel empowered to schedule a consultation and learn more."

 

Natrelle breast implants, the company’s flagship line, are positioned as part of a 50-year legacy in breast aesthetics. The product range offers multiple profiles and gel cohesivities designed to allow surgeons to tailor outcomes to individual patients.